annual EBITDA:
$31.73M+$94.78M(+150.32%)Summary
- As of today (June 1, 2025), AUPH annual EBITDA is $31.73 million, with the most recent change of +$94.78 million (+150.32%) on December 31, 2024.
- During the last 3 years, AUPH annual EBITDA has risen by +$209.17 million (+117.88%).
- AUPH annual EBITDA is now at all-time high.
Performance
AUPH EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBITDA:
$30.27M+$23.09M(+321.56%)Summary
- As of today (June 1, 2025), AUPH quarterly EBITDA is $30.27 million, with the most recent change of +$23.09 million (+321.56%) on March 31, 2025.
- Over the past year, AUPH quarterly EBITDA has increased by +$34.15 million (+880.21%).
- AUPH quarterly EBITDA is now at all-time high.
Performance
AUPH quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
$65.88M+$34.15M(+107.64%)Summary
- As of today (June 1, 2025), AUPH TTM EBITDA is $65.88 million, with the most recent change of +$34.15 million (+107.64%) on March 31, 2025.
- Over the past year, AUPH TTM EBITDA has increased by +$105.03 million (+268.26%).
- AUPH TTM EBITDA is now at all-time high.
Performance
AUPH TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
AUPH EBITDA Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +150.3% | +880.2% | +268.3% |
3 y3 years | +117.9% | +181.7% | +140.1% |
5 y5 years | +135.3% | +221.8% | +164.2% |
AUPH EBITDA Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | at high | +117.9% | at high | +181.7% | at high | +140.1% |
5 y | 5-year | at high | +117.9% | at high | +160.4% | at high | +137.1% |
alltime | all time | at high | +117.9% | at high | +160.4% | at high | +137.1% |
AUPH EBITDA History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2025 | - | $30.27M(+321.6%) | $65.88M(+107.6%) |
Dec 2024 | $31.73M(-150.3%) | $7.18M(-65.7%) | $31.73M(+622.7%) |
Sep 2024 | - | $20.91M(+178.1%) | $4.39M(-119.1%) |
Jun 2024 | - | $7.52M(-293.8%) | -$23.00M(-41.2%) |
Mar 2024 | - | -$3.88M(-80.8%) | -$39.15M(-31.6%) |
Dec 2023 | -$63.05M(-39.2%) | -$20.16M(+210.7%) | -$57.22M(-7.8%) |
Sep 2023 | - | -$6.49M(-24.8%) | -$62.04M(-1.2%) |
Jun 2023 | - | -$8.63M(-60.7%) | -$62.77M(-29.3%) |
Mar 2023 | - | -$21.95M(-12.1%) | -$88.81M(-14.5%) |
Dec 2022 | -$103.65M(-41.6%) | -$24.97M(+245.6%) | -$103.91M(-5.9%) |
Sep 2022 | - | -$7.23M(-79.2%) | -$110.38M(-27.7%) |
Jun 2022 | - | -$34.67M(-6.4%) | -$152.74M(-7.1%) |
Mar 2022 | - | -$37.04M(+17.8%) | -$164.36M(-7.4%) |
Dec 2021 | -$177.44M(+72.4%) | -$31.45M(-36.6%) | -$177.44M(+15.5%) |
Sep 2021 | - | -$49.59M(+7.1%) | -$153.64M(+5.2%) |
Jun 2021 | - | -$46.29M(-7.7%) | -$146.03M(+15.8%) |
Mar 2021 | - | -$50.13M(+555.9%) | -$126.11M(+25.1%) |
Dec 2020 | -$102.92M(+14.6%) | -$7.64M(-81.8%) | -$100.83M(-26.3%) |
Sep 2020 | - | -$41.97M(+59.2%) | -$136.83M(+20.6%) |
Jun 2020 | - | -$26.37M(+6.1%) | -$113.48M(+10.6%) |
Mar 2020 | - | -$24.85M(-43.1%) | -$102.60M(+14.3%) |
Dec 2019 | -$89.77M(+64.4%) | -$43.65M(+134.5%) | -$89.77M(+71.3%) |
Sep 2019 | - | -$18.61M(+20.2%) | -$52.40M(+1.3%) |
Jun 2019 | - | -$15.49M(+28.9%) | -$51.72M(+0.4%) |
Mar 2019 | - | -$12.02M(+91.5%) | -$51.53M(-5.6%) |
Dec 2018 | -$54.59M(+19.7%) | -$6.28M(-65.0%) | -$54.59M(-9.2%) |
Sep 2018 | - | -$17.93M(+17.2%) | -$60.10M(+8.1%) |
Jun 2018 | - | -$15.30M(+1.5%) | -$55.59M(+11.3%) |
Mar 2018 | - | -$15.08M(+28.0%) | -$49.97M(+9.6%) |
Dec 2017 | -$45.61M(+113.8%) | -$11.78M(-12.3%) | -$45.61M(+9.9%) |
Sep 2017 | - | -$13.43M(+38.7%) | -$41.49M(+25.4%) |
Jun 2017 | - | -$9.68M(-9.7%) | -$33.09M(+19.9%) |
Mar 2017 | - | -$10.72M(+40.0%) | -$27.60M(+29.4%) |
Dec 2016 | -$21.34M(-3.1%) | -$7.66M(+52.3%) | -$21.34M(+13.3%) |
Sep 2016 | - | -$5.03M(+20.1%) | -$18.84M(-4.9%) |
Jun 2016 | - | -$4.19M(-6.1%) | -$19.80M(-7.1%) |
Mar 2016 | - | -$4.46M(-13.6%) | -$21.30M(-3.3%) |
Dec 2015 | -$22.02M(+23.2%) | -$5.16M(-13.9%) | -$22.02M(-10.3%) |
Sep 2015 | - | -$5.99M(+5.4%) | -$24.56M(+78.6%) |
Jun 2015 | - | -$5.69M(+9.9%) | -$13.75M(-26.6%) |
Mar 2015 | - | -$5.18M(-32.7%) | -$18.73M(+4.5%) |
Dec 2014 | -$17.87M(+217.0%) | -$7.70M(-259.9%) | -$17.93M(+58.5%) |
Sep 2014 | - | $4.81M(-145.1%) | -$11.31M(-40.9%) |
Jun 2014 | - | -$10.66M(+143.7%) | -$19.13M(+105.0%) |
Mar 2014 | - | -$4.38M(+306.3%) | -$9.34M(+65.6%) |
Dec 2013 | -$5.64M(-36.1%) | -$1.08M(-64.3%) | -$5.64M(-40.7%) |
Sep 2013 | - | -$3.02M(+248.3%) | -$9.50M(+19.2%) |
Jun 2013 | - | -$866.00K(+27.5%) | -$7.97M(-13.3%) |
Mar 2013 | - | -$679.00K(-86.3%) | -$9.20M(+5.0%) |
Dec 2012 | -$8.83M(+510.8%) | -$4.94M(+232.5%) | -$8.76M(+475.1%) |
Sep 2012 | - | -$1.49M(-29.0%) | -$1.52M(+66.6%) |
Jun 2012 | - | -$2.09M(+773.6%) | -$914.20K(-114.5%) |
Mar 2012 | - | -$239.50K(-110.4%) | $6.31M(+26.2%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2011 | -$1.45M(-65.8%) | $2.29M(-361.6%) | $5.00M(+832.0%) |
Sep 2011 | - | -$876.90K(-117.1%) | $536.10K(+110.9%) |
Jun 2011 | - | $5.13M(-431.0%) | $254.20K(-105.0%) |
Mar 2011 | - | -$1.55M(-28.5%) | -$5.07M(+20.3%) |
Dec 2010 | -$4.23M(-32.8%) | -$2.17M(+86.9%) | -$4.22M(+240.2%) |
Sep 2010 | - | -$1.16M(+478.8%) | -$1.24M(-26.0%) |
Jun 2010 | - | -$200.20K(-71.1%) | -$1.67M(-55.5%) |
Mar 2010 | - | -$691.60K(-185.3%) | -$3.76M(-32.3%) |
Dec 2009 | -$6.28M(-55.8%) | $811.10K(-150.9%) | -$5.56M(-23.5%) |
Sep 2009 | - | -$1.59M(-30.3%) | -$7.27M(-20.4%) |
Jun 2009 | - | -$2.29M(-8.1%) | -$9.13M(-24.3%) |
Mar 2009 | - | -$2.49M(+176.8%) | -$12.06M(-16.3%) |
Dec 2008 | -$14.22M(-58.3%) | -$898.40K(-74.0%) | -$14.42M(-33.2%) |
Sep 2008 | - | -$3.46M(-33.8%) | -$21.60M(-16.7%) |
Jun 2008 | - | -$5.22M(+7.8%) | -$25.92M(-13.9%) |
Mar 2008 | - | -$4.84M(-40.0%) | -$30.10M(-5.8%) |
Dec 2007 | -$34.12M(+51.0%) | -$8.08M(+3.8%) | -$31.95M(+7.6%) |
Sep 2007 | - | -$7.78M(-17.3%) | -$29.69M(+5.6%) |
Jun 2007 | - | -$9.40M(+40.3%) | -$28.11M(+14.6%) |
Mar 2007 | - | -$6.70M(+15.4%) | -$24.52M(+9.8%) |
Dec 2006 | -$22.60M(-19.7%) | -$5.81M(-6.3%) | -$22.33M(-6.7%) |
Sep 2006 | - | -$6.20M(+6.7%) | -$23.94M(-1.1%) |
Jun 2006 | - | -$5.81M(+28.6%) | -$24.20M(-3.1%) |
Mar 2006 | - | -$4.52M(-39.0%) | -$24.97M(-8.8%) |
Dec 2005 | -$28.15M(+35.1%) | -$7.41M(+14.7%) | -$27.39M(-2.0%) |
Sep 2005 | - | -$6.46M(-1.8%) | -$27.95M(+0.9%) |
Jun 2005 | - | -$6.58M(-5.1%) | -$27.69M(+13.5%) |
Mar 2005 | - | -$6.94M(-13.0%) | -$24.41M(+19.1%) |
Dec 2004 | -$20.83M(+111.9%) | -$7.97M(+28.5%) | -$20.50M(+18.3%) |
Sep 2004 | - | -$6.20M(+88.4%) | -$17.32M(+16.0%) |
Jun 2004 | - | -$3.29M(+8.8%) | -$14.94M(+113.1%) |
Mar 2004 | - | -$3.03M(-36.9%) | -$7.01M(+0.6%) |
Dec 2003 | -$9.83M(+1040.3%) | -$4.79M(+25.5%) | -$6.97M(+40.3%) |
Sep 2003 | - | -$3.82M(-182.5%) | -$4.97M(-803.0%) |
Jun 2003 | - | $4.63M(-255.1%) | $706.50K(-148.6%) |
Mar 2003 | - | -$2.99M(+7.0%) | -$1.45M(+97.4%) |
Dec 2002 | -$862.00K(-88.0%) | -$2.79M(-250.8%) | -$736.90K(-135.9%) |
Sep 2002 | - | $1.85M(-25.1%) | $2.06M(-197.5%) |
Jun 2002 | - | $2.47M(-209.0%) | -$2.11M(-72.8%) |
Mar 2002 | - | -$2.27M(-1.8%) | -$7.76M(-24.2%) |
Dec 2001 | -$7.20M(+13.7%) | - | - |
Aug 2001 | - | -$2.31M(-27.4%) | -$10.23M(+9.5%) |
May 2001 | - | -$3.18M(+42.3%) | -$9.35M(+19.3%) |
Feb 2001 | - | -$2.24M(-10.7%) | -$7.84M(+23.2%) |
Nov 2000 | -$6.33M(+482.5%) | -$2.50M(+75.6%) | -$6.36M(+44.3%) |
Aug 2000 | - | -$1.43M(-14.5%) | -$4.40M(+47.9%) |
May 2000 | - | -$1.67M(+120.1%) | -$2.98M(+73.7%) |
Feb 2000 | - | -$758.10K(+37.5%) | -$1.71M(+57.4%) |
Nov 1999 | -$1.09M(-44.4%) | -$551.30K(<-9900.0%) | -$1.09M(+102.5%) |
Aug 1999 | - | $0.00(-100.0%) | -$538.00K(0.0%) |
May 1999 | - | -$405.40K(+205.7%) | -$538.00K(+305.7%) |
Feb 1999 | - | -$132.60K | -$132.60K |
Nov 1998 | -$1.95M | - | - |
FAQ
- What is Aurinia Pharmaceuticals annual EBITDA?
- What is the all time high annual EBITDA for Aurinia Pharmaceuticals?
- What is Aurinia Pharmaceuticals annual EBITDA year-on-year change?
- What is Aurinia Pharmaceuticals quarterly EBITDA?
- What is the all time high quarterly EBITDA for Aurinia Pharmaceuticals?
- What is Aurinia Pharmaceuticals quarterly EBITDA year-on-year change?
- What is Aurinia Pharmaceuticals TTM EBITDA?
- What is the all time high TTM EBITDA for Aurinia Pharmaceuticals?
- What is Aurinia Pharmaceuticals TTM EBITDA year-on-year change?
What is Aurinia Pharmaceuticals annual EBITDA?
The current annual EBITDA of AUPH is $31.73M
What is the all time high annual EBITDA for Aurinia Pharmaceuticals?
Aurinia Pharmaceuticals all-time high annual EBITDA is $31.73M
What is Aurinia Pharmaceuticals annual EBITDA year-on-year change?
Over the past year, AUPH annual EBITDA has changed by +$94.78M (+150.32%)
What is Aurinia Pharmaceuticals quarterly EBITDA?
The current quarterly EBITDA of AUPH is $30.27M
What is the all time high quarterly EBITDA for Aurinia Pharmaceuticals?
Aurinia Pharmaceuticals all-time high quarterly EBITDA is $30.27M
What is Aurinia Pharmaceuticals quarterly EBITDA year-on-year change?
Over the past year, AUPH quarterly EBITDA has changed by +$34.15M (+880.21%)
What is Aurinia Pharmaceuticals TTM EBITDA?
The current TTM EBITDA of AUPH is $65.88M
What is the all time high TTM EBITDA for Aurinia Pharmaceuticals?
Aurinia Pharmaceuticals all-time high TTM EBITDA is $65.88M
What is Aurinia Pharmaceuticals TTM EBITDA year-on-year change?
Over the past year, AUPH TTM EBITDA has changed by +$105.03M (+268.26%)